Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

January’s top stories: J&J to acquire Actelion for $30bn, Takeda to acquire ARIAD for $5.2bn

J&J agreed to acquire Swiss biotech company Actelion for $30bn, and Japan’s Takeda agreed to acquire US cancer drug manufacturer ARIAD for $5.2bn. wraps up the key headlines from January.

Go Top